{"id":"https://openalex.org/W4361940966","doi":"https://doi.org/10.1158/1535-7163.22485723","title":"Supplementary Table from AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies","display_name":"Supplementary Table from AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361940966","doi":"https://doi.org/10.1158/1535-7163.22485723"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22485723","doi":"https://doi.org/10.1158/1535-7163.22485723","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22485723","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_from_AZD7762_a_novel_checkpoint_kinase_inhibitor_drives_checkpoint_abrogation_and_potentiates_DNA-targeted_therapies/22485723/1/files/39937284.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_from_AZD7762_a_novel_checkpoint_kinase_inhibitor_drives_checkpoint_abrogation_and_potentiates_DNA-targeted_therapies/22485723/1/files/39937284.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111904185","display_name":"Sonya Zabludoff","orcid":"https://orcid.org/0000-0003-1786-6241","observed_orcids":["https://orcid.org/0000-0003-1786-6241"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sonya D. Zabludoff","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Chun Deng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chun Deng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049708947","display_name":"Michael R. Grondine","orcid":"https://orcid.org/0000-0001-7806-1864","observed_orcids":["https://orcid.org/0000-0001-7806-1864"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael R. Grondine","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045342674","display_name":"Adam M. Sheehy","orcid":"https://orcid.org/0000-0003-0080-8950","observed_orcids":["https://orcid.org/0000-0003-0080-8950"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adam M. Sheehy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108554420","display_name":"Susan Ashwell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susan Ashwell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078911329","display_name":"Benjamin L. Caleb","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin L. Caleb","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Stephen Green","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen Green","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044579265","display_name":"Heather R. Haye","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Heather R. Haye","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090689034","display_name":"Candice L. Horn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Candice L. Horn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049539326","display_name":"James W. Janetka","orcid":"https://orcid.org/0000-0002-9888-5411","observed_orcids":["https://orcid.org/0000-0002-9888-5411"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James W. Janetka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084853102","display_name":"Dongfang Liu","orcid":"https://orcid.org/0000-0002-8801-2190","observed_orcids":["https://orcid.org/0000-0002-8801-2190","https://orcid.org/0009-0001-9241-2218","https://orcid.org/0009-0001-3699-4751"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dongfang Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011030371","display_name":"Elizabeth Mouchet","orcid":"https://orcid.org/0000-0003-3157-9388","observed_orcids":["https://orcid.org/0000-0003-3157-9388"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth Mouchet","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000162965","display_name":"Shannon Ready","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shannon Ready","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056285125","display_name":"Judith L. Rosenthal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Judith L. Rosenthal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067308803","display_name":"Christophe Qu\u00e9va","orcid":"https://orcid.org/0000-0002-3693-2972","observed_orcids":["https://orcid.org/0000-0002-3693-2972"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christophe Queva","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006913373","display_name":"Gary K. Schwartz","orcid":"https://orcid.org/0000-0003-1813-5061","observed_orcids":["https://orcid.org/0000-0003-1813-5061"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gary K. Schwartz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077035638","display_name":"Karen J. Taylor","orcid":"https://orcid.org/0000-0002-2265-5097","observed_orcids":["https://orcid.org/0000-0002-2265-5097"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karen J. Taylor","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114045976","display_name":"Archie N. Tse","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Archie N. Tse","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061486623","display_name":"Graeme E. Walker","orcid":"https://orcid.org/0000-0001-5344-9942","observed_orcids":["https://orcid.org/0000-0001-5344-9942"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Graeme E. Walker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Anne M. White","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne M. White","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.48410001397132874,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.48410001397132874,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.1582999974489212,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.09610000252723694,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/azd7762","display_name":"AZD7762","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7829999923706055},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.4690000116825104},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.5220000147819519}],"concepts":[{"id":"https://openalex.org/C2910325170","wikidata":"https://www.wikidata.org/wiki/Q14912280","display_name":"Checkpoint Kinase 2","level":5,"score":0.6233224272727966},{"id":"https://openalex.org/C54086632","wikidata":"https://www.wikidata.org/wiki/Q5512671","display_name":"G2-M DNA damage checkpoint","level":5,"score":0.6145252585411072},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5347529649734497},{"id":"https://openalex.org/C50001416","wikidata":"https://www.wikidata.org/wiki/Q17861750","display_name":"CHEK1","level":5,"score":0.4861835837364197},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.3897901475429535},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3522864580154419},{"id":"https://openalex.org/C105696609","wikidata":"https://www.wikidata.org/wiki/Q1068809","display_name":"Cell cycle checkpoint","level":4,"score":0.28863096237182617},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.23128530383110046},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.18493765592575073},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16908621788024902},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.15049946308135986},{"id":"https://openalex.org/C2910050888","wikidata":"https://www.wikidata.org/wiki/Q4857068","display_name":"Protein-Serine-Threonine Kinases","level":4,"score":0.13812410831451416},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.11757591366767883},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.09493294358253479}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.22485723","doi":"https://doi.org/10.1158/1535-7163.22485723","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22485723","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_from_AZD7762_a_novel_checkpoint_kinase_inhibitor_drives_checkpoint_abrogation_and_potentiates_DNA-targeted_therapies/22485723/1/files/39937284.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1535-7163.22485723.v1","doi":"https://doi.org/10.1158/1535-7163.22485723.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22485723.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22485723","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_from_AZD7762_a_novel_checkpoint_kinase_inhibitor_drives_checkpoint_abrogation_and_potentiates_DNA-targeted_therapies/22485723","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22485723","doi":"https://doi.org/10.1158/1535-7163.22485723","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22485723","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_from_AZD7762_a_novel_checkpoint_kinase_inhibitor_drives_checkpoint_abrogation_and_potentiates_DNA-targeted_therapies/22485723/1/files/39937284.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361940966.pdf","grobid_xml":"https://content.openalex.org/works/W4361940966.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2162730779","https://openalex.org/W4361954211","https://openalex.org/W2281059672","https://openalex.org/W4246488746","https://openalex.org/W2168765941","https://openalex.org/W2604598757","https://openalex.org/W3083442519","https://openalex.org/W2324690291","https://openalex.org/W2562755390","https://openalex.org/W4361875573"],"abstract_inverted_index":{"Supplementary":[0],"Table":[1],"from":[2],"AZD7762,":[3],"a":[4],"novel":[5],"checkpoint":[6,10],"kinase":[7],"inhibitor,":[8],"drives":[9],"abrogation":[11],"and":[12],"potentiates":[13],"DNA-targeted":[14],"therapies":[15]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}